The evolution of AIDS epidemic in China and progress in prevention and control strategies

TANG Houlin

doi:10.19837/j.cnki.ahyf.2025.06.001

PDF(1084 KB)

Anhui Journal of Preventive Medicine ›› 2025, Vol. 31 ›› Issue (6) : 437-441. DOI: 10.19837/j.cnki.ahyf.2025.06.001

Invited Paper

The evolution of AIDS epidemic in China and progress in prevention and control strategies

TANG Houlin

Author information +

History +

Abstract

Since the first case of acquired immunodeficiency syndrome (AIDS) was reported in China in 1985, the epidemic of AIDS has undergone a complex evolution from an imported period, a diffusion period, to a generalized epidemic phase predominantly driven by sexual transmission. This article systematically reviews epidemic evolution, stage-specific characteristics, major achievements of prevention and control strategies, and current challenges of the AIDS in China. Through in-depth analysis of the national policies evolution, improvements of surveillance and detection system, expansion of treatment and care services, deepening of public health education, and coordinated prevention and control of multiple diseases, the important experience of AIDS prevention and control in China is summarized. In light of challenges such as difficulties in prevention and control of key populations, delayed detection, uneven prevention and control capabilities, and so on, the direction for future prevention and control work is discussed. It emphasizes the need to advance targeted interventions, strengthen system integration, and promote co-governance involving all sectors of society, thereby offering insights for achieving the goal of ending the AIDS epidemic.

Key words

AIDS / Epidemiological characteristics / Prevention and control / Strategy / Public health

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

TANG Houlin. The evolution of AIDS epidemic in China and progress in prevention and control strategies[J]. Anhui Journal of Preventive Medicine. 2025, 31(6): 437-441 https://doi.org/10.19837/j.cnki.ahyf.2025.06.001

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	中国疾病预防控制中心性病艾滋病预防控制中心. 2024年12月全国艾滋病性病疫情[J]. 中国艾滋病性病, 2025, 31(3):225. Cited in this article [3]

[2]	Wu ZY, Chen JF, Scott SR, et al. History of the HIV epidemic in China[J]. Curr HIV/AIDS Rep, 2019, 16(6):458-466. https://doi.org/10.1007/s11904-019-00471-4 Cited in this article [3]

[3]	曾毅, 王必瑺, 郑锡文, 等. 艾滋病的血清流行病学调查研究[J]. 中华流行病学杂志, 1988, 9(3):138-140. Cited in this article [1]

[4]	Cai C, Tang HL, Li DM, et al. Evolution of HIV epidemic and emerging challenges - China,1989-2023[J]. China CDC Wkly, 2024, 6(48):1251-1256. Cited in this article [5]

[5]	Wu ZY, Sullivan SG, Wang Y, et al. Evolution of China’s response to HIV/AIDS[J]. Lancet, 2007, 369(9562):679-690. https://doi.org/10.1016/S0140-6736(07)60315-8 https://linkinghub.elsevier.com/retrieve/pii/S0140673607603158 Cited in this article [2]

[6]

, Han

, Jiang

, et al. Prevention and control of HIV/AIDS in China:lessons from the past three decades[J]. Chin Med J, 2021, 134(23):2799-2809.

https://doi.org/10.1097/CM9.0000000000001842

https://journals.lww.com/10.1097/CM9.0000000000001842

Cited in this article [1] Abstract

In the past 37 years, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) has undergone various major transmission routes in China, with the world most complex co-circulating HIV-1 subtypes, even the prevalence is still low. In response to the first epidemic outbreak of HIV in injecting drug users and the second one by illegal commercial blood collection, China issued the Anti-Drug Law and launched the Blood Donation Act and nationwide nucleic acid testing, which has avoided 98,232 to 211,200 estimated infections and almost ended the blood product-related infection. China has been providing free antiretroviral therapy (ART) since 2003, which covered >80% of the identified patients and achieved a viral suppression rate of 91%. To bend the curve of increasing the disease burden of HIV and finally end the epidemic, China should consider constraining HIV spread through sexual transmission, narrowing the gaps in identifying HIV cases, and the long-term effectiveness and safety of ART in the future.

[7]	韩孟杰. 我国艾滋病流行形势分析和防治展望[J]. 中国艾滋病性病, 2023, 29(3):247-250. Cited in this article [4]

[8]	中国疾病预防控制中心性病艾滋病预防控制中心. 2023年12月全国艾滋病性病疫情[J]. 中国艾滋病性病, 2024, 30(3):225. Cited in this article [1]

[9]	中华人民共和国国务院. 艾滋病防治条例[EB/OL]. (2006-01-29) [2025-10-20]. https://www.gov.cn/flfg/2006-02/12/content_186324.htm. https://www.gov.cn/flfg/2006-02/12/content_186324.htm Cited in this article [1]

[10]	国务院办公厅. 国办印发《中国遏制与防治艾滋病规划(2024—2030年)》[EB/OL]. (2024-12-12) [2025-10-20]. http://cpc.people.com.cn/n1/2024/1212/c64387-40380460.html. http://cpc.people.com.cn/n1/2024/1212/c64387-40380460.html Cited in this article [2]

[11]	国务院办公厅. 国务院办公厅关于印发中国遏制与防治艾滋病行动计划(2006—2010年)的通知[EB/OL]. (2006-02-27) [2025-10-20]. https://www.gov.cn/zwgk/2006-03/10/content_224306.htm. https://www.gov.cn/zwgk/2006-03/10/content_224306.htm Cited in this article [1]

[12]	国务院办公厅. 国务院办公厅关于印发中国遏制与防治艾滋病“十二五”行动计划的通知[EB/OL]. (2012-01-13) [2025-10-20]. https://www.gov.cn/zwgk/2012-02/29/content_2079097.htm. https://www.gov.cn/zwgk/2012-02/29/content_2079097.htm Cited in this article [1]

[13]	国务院办公厅. 国务院办公厅关于印发中国遏制与防治艾滋病“十三五”行动计划的通知[EB/OL]. (2017-01-19) [2025-10-20]. https://www.gov.cn/zhengce/zhengceku/2017-02/05/content_5165514.htm. https://www.gov.cn/zhengce/zhengceku/2017-02/05/content_5165514.htm Cited in this article [1]

[14]	郝阳, 孙新华, 夏刚, 等. “四免一关怀”政策实施10年中国艾滋病防治主要进展[J]. 中国艾滋病性病, 2014, 20(4):228-232. Cited in this article [1]

[15]	吕柯, 徐鹏. 从艾滋病流行形势看我国当前所处发展阶段与防治策略[J]. 中国艾滋病性病, 2025, 31(4):429-432. Cited in this article [1]

[16]	徐鹏, 韩孟杰, 吕繁, 等. 我国艾滋病防治工作高质量发展的循证基础和践行策略[J]. 中国艾滋病性病, 2023, 29(5):491-493. Cited in this article [9]

[17]	韩孟杰, 陈清峰, 徐鹏, 等. 砥砺奋进“十三五” 艾滋病防控迈向新征程:国艾滋病防治回顾与展望[J]. 中国艾滋病性病, 2021, 27(12):1327-1331. Cited in this article [3]

[18]	Jiang Y, Qiu MF, Zhang GY, et al. Quality assurance in the HIV/AIDS laboratory network of China[J]. Int J Epidemiol, 2010, 39(Suppl 2):ii72-ii78. Cited in this article [1]

[19]	Tucker JD, Cohen MS. China’s syphilis epidemic:epidemiology,proximate determinants of spread,and control responses[J]. Curr Opin Infect Dis, 2011, 24(1):50-55. https://doi.org/10.1097/QCO.0b013e32834204bf http://journals.lww.com/00001432-201102000-00009 Cited in this article [1]

[20]	Su R, Liu Y, Shan D, et al. Prevalence of HIV/syphilis co-infection among men who have sex with men in China:a systematic review and meta-analysis[J]. BMC Public Health, 2025, 25(1):1297. https://doi.org/10.1186/s12889-025-22499-5 Cited in this article [1]

[21]	Zhang HX, Hsieh E, Wang L, et al. HIV/AIDS among female sex workers in China:epidemiology and recent prevention strategies[J]. Curr HIV/AIDS Rep, 2020, 17(2):151-160. https://doi.org/10.1007/s11904-019-00477-y Cited in this article [1]

[22]

Sun

, Li

, Liu

, et al. HIV/AIDS late presentation and its associated factors in China from 2010 to 2020:a systematic review and meta-analysis[J]. AIDS Res Ther, 2021, 18(1):96.

https://doi.org/10.1186/s12981-021-00415-2

Cited in this article [2] Abstract

Late presentation to HIV/AIDS care presents serious health concerns, like increased transmission and high healthcare costs, increased mortality, early development of opportunistic infection, increased risk of antiretroviral therapy drug resistance. Despite the effort to contain the HIV/AIDS epidemic, LP has remained an impediment to individual immune reconstitution and public health.

[23]	郑雅静. 我国HIV/AIDS病例晚发现影响因素的研究进展[J]. 广州医科大学学报, 2020, 48(6):124-127. Cited in this article [1]

[24]	吕繁, 刘中夫, 刘玉芬, 等. 锚定目标提升能力促进艾滋病防治高质量发展[J]. 中国艾滋病性病, 2024, 30(4):335-338. Cited in this article [1]

[25]	Zhang XL, Miège P, Zhang YR. Decentralization of the provision of health services to people living with HIV/AIDS in rural China:the case of three counties[J]. Health Res Policy Syst, 2011, 9:9. Cited in this article [1]

[26]	何慧婧, 吕繁, 栾荣生, 等. 影响男男性行为人群HIV传播的社会文化因素定性研究[J]. 中华预防医学杂志, 2016, 50(10):858-862. Cited in this article [1]

[27]	吕繁. 中国艾滋病防治策略[J]. 中华预防医学杂志, 2016, 50(10): 841-845. Cited in this article [1]

[28]	汤后林, 金怡晨, 吕繁. 我国老年人群艾滋病防控现状与挑战[J]. 中华流行病学杂志, 2023, 44(11):1669-1672. Cited in this article [1]

[29]	汤后林, 吕繁. 数字技术赋能艾滋病防控的应用、挑战与对策[J]. 中国艾滋病性病, 2025, 31(3):325-330. Cited in this article [1]